PALOXI 0.25 INJ. contains Palonosetron 0.25 mg. It is a 5-HT3 receptor antagonist (antiemetic) medicine used to prevent and control nausea and vomiting associated with chemotherapy and surgical procedures.
Uses:
-
Prevention of chemotherapy-induced nausea and vomiting
-
Prevention of nausea and vomiting after surgery
-
Management of delayed nausea and vomiting caused by chemotherapy
-
Helps control nausea by blocking serotonin activity in the body
Dose:
-
Adults: Usually 0.25 mg as a single intravenous dose before chemotherapy or as directed by a physician
-
Administered by intravenous injection under medical supervision
-
Dose and timing depend on the treatment plan and patient condition
-
Use only as directed by a healthcare professional
-
Do not change the dose or frequency without medical advice